Michael Schlander spoke on "Social Willingness to Pay” and the case for “Social Cost Value Analysis” at the International Symposium on “Accessibility to High-Value Medicines" (London School of Hygiene & Tropical Medicine), in London / England, on December 6, 2017.
At the 20th European Congress of ISPOR in Glasgow, Scotland, Michael Schlander was interviewed by Cathy Jordan from GalbraithWight, answering questions on topical subjects and controversies in the field of health economics.
Michael Schlander spoke on the subjects "Is NICE in the UK more Innovation-Friendly than IQWiG/GBA in Germany?" and "An Update on the Economic Value of a Statistical Life Year in Europe" at the "XIV HTAi 2017 Annual Meeting" in Rome / Italy, June 17-21, 2017.
Michael Schlander spoke on “Health Technology Assessment (HTA) for Medical Products – How to Cope with the Increasing Regulatory Burden?” at the upcoming MedTech Dialogue Meeting in Mannheim / Germany, on March 23, 2017.